Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Completed · Phase 3

Conditions studied: Bipolar I Disorder

In brief

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.

Key facts

Study ID

NCT00046384

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

Starts

2002-06-01

Expected to finish

2003-04-01

Last updated by the study team

2013-11-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Local Institution — Scottsdale, Arizona, United States
• Local Institution — Little Rock, Arkansas, United States
• Local Institution — Chula Vista, California, United States
• Local Institution — Pico Rivera, California, United States
• Local Institution — Riverside, California, United States
• Local Institution — San Diego, California, United States
• Local Institution — Washington D.C., District of Columbia, United States
• Local Institution — Winter Park, Florida, United States
• Local Institution — Staten Island, New York, United States
• Local Institution — Oklahoma City, Oklahoma, United States
• Local Institution — Nashville, Tennessee, United States
• Local Institution — Falls Church, Virginia, United States
• Local Institution — Bellevue, Washington, United States
• Local Institution — Mendoza, Argentina

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.